Renal Denervation procedure across its health system, targeting patients with uncontrolled high blood pressure--a therapy shown in clinical trials to reduce major cardiovascular events by 20%, stroke ...

Add Yahoo as a preferred source to see more of our stories on Google. Findings support sacubitril/valsartan's role as a potentially valuable late-line therapy for resistant hypertension. Credit: ABO ...

High blood pressure impacts around one in every four adults in India and leads to over 1.6 million deaths annually. While it ...

High blood pressure, or hypertension, is often called the 'silent killer.' While medication remains the primary treatment, for some, even optimal medication and lifestyle changes fail to bring blood ...

Findings showed treatment with lorundrostat resulted in statistically significant reductions in systolic blood pressure compared with placebo. Topline data were announced from a phase 3 trial ...

Amiloride is noninferior to spironolactone in lowering home systolic blood pressure over 12 weeks in patients with resistant hypertension. The finding is from the SPironolactone Versus Amiloride for ...

According to the World Health Organization, hypertension-or high blood pressure-affects nearly 220 million people in India, yet only 12% of them have it under control. For most, a healthy lifestyle ...

SaveHealth reports on 10 hypertension medications, their classifications, effectiveness, side effects, and safety in managing high blood pressure.

Baxdrostat demonstrated a statistically significant and highly clinically meaningful reduction in 24-hour ambulatory systolic blood pressure compared with placebo WILMINGTON, Del.--(BUSINESS WIRE)-- ...